All Type of News
Celltrion makes KRW 263.4 billion sales in 2nd quarter
On the 8th, Celltrion gave a notice about the company’s 2018 2nd quarter consolidated business performance that they had a 7% increase to KRW 263.4 billion sales, but a 21.7% decrease to KRW 108.2 billion operating pr...
Pharmacy society has a hard time when returning Chinese ‘Valsaltan’ ingredients
In a process of exchanging drugs containing Valsartan ingredients with carcinogenic factors, pharmacies are having trouble with patients over calculating patient-sharing expenses.
According to the pharmacy society, b...
Orphan drugs in development
Under the Orphan Drug Program enforced in 2013, total 18 products have been designated since the year.
According to the Ministry of Health and Welfare(MFDS), the government has introduced and enforced the Orphan Drug...
Samsung Group, “We’ll make biopharmaceutical field as the next semiconductor business”
Samsung Group will start to aggressively invest funds to make the biologic field to the next semiconductor business.
On the 8th, Samsung announced plans to invest total KRW 180 trillion for the next 3 years to contin...
“We accept necessity of adding antacids into the emergency household medicines list”
As necessity of adding antacids in the list of emergency household medicines is accepted, they will discuss about which specific products to add in the list.
The Ministry of Health and Welfare(Minister Neung-Hoo Park...
Obligation to submit written statement for no response to medical dispute mediation
A bill will be introduced to turn in a written statement for not responding to a medical dispute mediation.
The Minjoo Party Rep. Sang-Hee Kim representatively tabled the ‘Partial Revision Bill to the Medical Inciden...
Organization of Legalizing Medical Cannabis in Korea founds Korea Cannabinoid Association
The Organization of Legalizing Medical Cannabis in Korea, which had the foundation meeting in 2017, will found the ‘Korea Cannabinoid Association,’ a non-governmental organization, at Patriot Ahn Jung Geun Memorial Ha...
Celltrion starts Phase I and Phase III clinical trials for Humira biosimilar
Celltrion recently announced that they made a clinical trial application for ‘CT-P17,’ a biosimilar referencing the rheumatoid arthritis therapy ‘Humira(generic name: adalimumab),’ to the U.K. Medicines and Healthcare...
MFDS extensively develop QbD mode to raise competitiveness of pharma industry
The Ministry of Food and Drug Safety(MFDS) will extensively develop the ‘Quality by Design(QbD) system’ model to strengthen completeness of the Korean pharmaceutical industry.
Quality by Design, a new paradigm in dru...
‘Final meeting’ for emergency household medicines starts finally
The final meeting arranged to adjust emergency household medicine products was held after the long postponement for 1 year and 6 months.
The Ministry of Health and Welfare(MOHW) held the ‘6th Deliberative Committee f...
